Synergistic interaction between oxaliplatin (L-OHP) and 5-Fluorouracil (5-FU)

被引：0
|
作者：
Ward, S [1 ]
Papamichael, D [1 ]
Locke, K [1 ]
Darke, C [1 ]
Joel, S [1 ]
机构：
[1] St Bartholomews Hosp, Dept Med Oncol, London, England
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
187
引用
收藏
页码：39 / 39
页数：1
相关论文
共 50 条
  • [31] Oxaliplatin (L-OHP) in combination with leucovorin and bolus-continuous infusion 5fluorouracil (LV5FU2) in advanced colorectal cancer (ACC) pretreated with 5FU
    Beretta, GD
    Cascinu, S
    Zaniboni, A
    Ratti, R
    Giordani, P
    Catalano, V
    Martignoni, G
    Barni, S
    Frontini, L
    Labianca, R
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S80 - S80
  • [32] Synergistic activity of the Akt inhibitor perifosine and 5-fluorouracil in 5-FU resistant gastric cancer
    Song, Kim Hyo
    Shin, You Keun
    Zhang, Xianglan
    Kim, Jung Min Kim
    Kim, Tae Soo
    Park, Chan Hee
    Jang, Woo Ick
    Engel, Juergen
    Rha, Sun Young Rha
    CANCER RESEARCH, 2013, 73 (08)
  • [33] Palliative therapy for advanced biliary tract carcinoma with oxaliplatin, 5-fluorouracil (5-FU) and leucovorin (LV).
    Nehis, O
    Klump, B
    Gregor, M
    Porschen, R
    GASTROENTEROLOGY, 2000, 118 (04) : A523 - A523
  • [34] Oxaliplatin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in patients with metastatic gastric cancer (MGC)
    Cavanna, Luigi
    Artioli, Fabrizio
    Codignola, Claudio
    Lazzaro, Antonio
    Rizzi, Anna
    Gamboni, Alessandro
    Rota, Luigina
    Rodino, Carmelina
    Boni, Fabrizio
    Iop, Aldo
    Zaniboni, Alberto
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (04): : 371 - 375
  • [35] Bolus 5-fluorouracil (5-FU) In Combination With Oxaliplatin Is Safe and Well Tolerated in Patients Who Experienced Coronary Vasospasm With Infusional 5-FU or Capecitabine
    Chakrabarti, Sakti
    Sara, Jaskanwal
    Lobo, Ronstan
    Eiring, Rachel
    Finnes, Heidi
    Mitchell, Jessica
    Hartgers, Mindy
    Okano, Akiko
    Halfdanarson, Thorvardur
    Grothey, Axel
    CLINICAL COLORECTAL CANCER, 2019, 18 (01) : 52 - 57
  • [36] L-OHP、5-Fu、CF化疗方案治疗晚期胃癌40例护理
    朱敏
    姜萍
    邵灵燕
    淮海医药, 2004, (01) : 55 - 55
  • [37] Selective delivery of 5-fluorouracil (5-FU) to ip tissues using 5-FU microspheres in rats
    Hagiwara, A
    Sakakura, C
    Tsujimoto, H
    Imanishi, T
    Ohgaki, M
    Yamasaki, J
    Sawai, K
    Takahashi, T
    Fujita, T
    Yamamoto, A
    Muranishi, S
    Ikada, Y
    ANTI-CANCER DRUGS, 1997, 8 (02) : 182 - 188
  • [38] The role of 5-fluorouracil (5-FU) reintroduction with irinotecan or oxaliplatin in truly 5-FU-refractory advanced colorectal cancer patients
    Scartozzi, M
    Sobrero, A
    Gasparini, G
    Berardi, R
    Catalano, V
    Graziano, F
    Barni, S
    Zaniboni, A
    Beretta, GD
    Labianca, R
    Cascinu, S
    ONCOLOGY, 2005, 68 (2-3) : 212 - 216
  • [39] L-OHP、FA、5-FU联用化疗的不良反应及治疗
    周荣军
    孙凤荣
    山东医药, 2005, (21) : 89 - 89
  • [40] Phase I/II study of oxaliplatin (L-OHP) plus 5-Fluorouracil concurrent with external beam radiotherapy (EBRT) in rectosigmoid carcinoma
    Cajal, TRY
    Rayo, SG
    Calvo, E
    Aristu, JJ
    Villafranca, E
    Cañón, R
    Moreno, M
    Hernández, JL
    Azinovic, I
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S76 - S76
12345